EUCTR2017-001779-22-DK进行中（未招募）1 期
The Effect of Empagliflozin on Cardiac and Kidney Metabolism in Persons with Type 2 Diabetes
Aarhus University Hospital, Department of Endocrinology0 个研究点目标入组 13 人开始时间: 2017年5月22日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 13
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age: 50-70 years
- •Type 2 diabetes for > 1 år
- •HbA1c: 53-75 mmol/mol
- •Metformin treatment as only anti diabetic medicin
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 9
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 3
排除标准
- •Diabetes for less than 1 year
- •Changes in any kind of medicine through the last one month before beginning of the study.
- •Recent acute myocardial infarction (< 1 year) , liver disease (ALAT > x 3 of upper normal range), kidney failure (eGFR<60 ml/min), current or previous cancer disease, anaemia (Hb < 6,5)
- •Previous ketoacidosis
- •Several genital infections (bacterial/fungal infections)
- •Blooddonation the last 3 months before beginning of the study
- •Participation in examinations with radioactive isotopes during the last 6 months before beginning of the study
- •Current alcohol abuse (more than 21 units per week)
研究者
相似试验
进行中（未招募）
1 期
The effect of treatment with Dapagliflozin on heart and kidney function after catheter based aortic valve replacement for aortic stenosisPatients with aortic stenosis undergoing trans catheter aortic valve replacement.MedDRA version: 20.0Level: LLTClassification code 10058186Term: Aortic valve stenosis and insufficiencySystem Organ Class: 100000004849EUCTR2021-004271-14-DKAarhus University Hospital, department of Cardiology104
进行中（未招募）
1 期
Effect of Dapagliflozin on myocardial and renal function following aortic valve stenosis interventioAortic stenosisCTIS2024-514868-11-00Aarhus Universitetshospital106
进行中（未招募）
1 期
Impact of Empagliflozin on heart in patients with myocardial infarctioMyocardial infarctionEUCTR2016-004591-22-ATMedical University of Graz/Department of Internal Medicine/Division of Endocrinology and Diabetology476
尚未招募
3 期
Effect of Empagliflozin on clinical and echocardiographic parameters in patient with reduced LVEF heart failureHeart failureIRCT20210809052117N1Shahid Beheshti University of Medical Sciences44
尚未招募
2 期
Efficacy of Empagliflozin on cardiac function in non- diabetic patients after primary percutaneous angioplasty on left anterior descending coronary arteryacute myocardial infarction.121-09IRCT20200727048226N1Tehran University of Medical Sciences88